Mindfulness Meditation in Glioma Patients

This pilot study is designed to determine the feasibility of providing a mindfulness meditation program to patients with newly diagnosed malignant glioma during standard of care chemoradiation. Newly diagnosed malignant glioma patients will participate in six 1-hour mindfulness sessions over the phone, followed by one 1-hour in-person mindfulness session. Patients will complete various Quality of Life questionnaires and distress measuring tools prior to initiating the mindfulness sessions, at the clinic visit following the mindfulness intervention, and \~2 months after completing the mindfulness intervention. Additionally, patients will be provided with supplemental materials including website references and guided audiotape meditations to guide their individual practice outside of the weekly guided sessions. The main objective of this study is to assess the feasibility of a mindfulness meditation intervention program, designed to mitigate the distress associated with the disease and first line treatment of patients with malignant glioma, and to determine whether it merits additional research in a subsequent trial. There are no risks associated with participation in this study.

Sex

All

Minimum age

18 Years

Inclusion Criteria:

1. ≥ 18 years of age
2. NCCN distress scale ≥ 4 OR at least one of the following problems indicated on the NCCN distress thermometer worksheet: depression, fears, nervousness, sadness, worry, loss of interest in usual activities, sleep, memory, or fatigue
3. Karnofsky Performance Status (KPS) ≥ 70
4. Patient must have histologically confirmed, newly diagnosed WHO grade III or IV malignant glioma
5. Patient must be prior to a planned 6-week standard of care chemoradiation regimen
6. Patient can speak, read, and write English
7. Patient has access to a telephone for mindfulness training
8. Patient has access to internet

Exclusion Criteria:

1. Patients previously or currently practicing or participating in mindfulness meditation practice
2. Intermittent or active psychosis
3. Psychiatric hospitalization within the last 6 months
4. Hospitalized in a rehab facility within the last 6 months for substance abuse